This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Eyegene Inc.. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2020
Title: Hyeong-Joon Lim: Innovator in Vascular Disease Treatment
Introduction
Hyeong-Joon Lim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing vascular-related diseases. With a total of 2 patents, Lim's work is paving the way for innovative therapeutic methods.
Latest Patents
Hyeong-Joon Lim's latest patents focus on a method for treating vascular-related diseases. This method involves administering a peptide with a specific sequence, Xaa-Gly-Asp, to subjects in need. The peptide may include sequences from SEQ ID NOS: 1, 2, 4, 6 to 10. The targeted vascular-related diseases include edema and ischemia, which can result from blood leakage from vessel walls, damage to blood vessels, or abnormal angiogenesis.
Career Highlights
Lim is currently associated with Eyegene Inc., where he continues to develop and refine his innovative approaches to medical treatments. His work is characterized by a commitment to improving patient outcomes through scientific advancements.
Collaborations
Some of Hyeong-Joon Lim's coworkers include Doo-Sik Kim and Yang-Je Cho. Their collaborative efforts contribute to the ongoing research and development in the field of vascular disease treatment.
Conclusion
Hyeong-Joon Lim's contributions to the medical field, particularly in treating vascular-related diseases, highlight his role as an influential inventor. His innovative methods and dedication to research are making a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile